Target intelligence / Profile preview

Inner mitochondrial membrane peptidase subunit 1 (IMMP1L)

Target
IMMP1L
Molecular classification
Enzyme (specifically, mitochondrial peptidase), Mitochondrial inner membrane protein, Protease
01

Overview

Inner mitochondrial membrane peptidase subunit 1 (IMMP1L) is an enzyme located in the inner membrane of mitochondria. IMMP1L acts as a catalytic subunit of the mitochondrial inner membrane peptidase (IMP) complex, which is responsible for the proteolytic cleavage of mitochondrial targeting sequences from precursor proteins imported into the mitochondrial intermembrane space. This processing is critical for the maturation and function of various nuclear-encoded mitochondrial proteins. The IMP complex in humans comprises two catalytic subunits, IMMP1L and IMMP2L. IMMP1L is highly conserved and structurally related to yeast Imp1. While IMMP1L’s biochemical role is presumed to be vital for mitochondrial protein maturation, current evidence does not identify it as a direct disease gene or drug target. Deletions encompassing IMMP1L have been observed in chromosomal rearrangements linked to ocular developmental disorders, but pathogenic effects are primarily attributed to regulatory disruption of neighboring critical genes such as PAX6.

Other names
IMMP1LIMP1-LIKEIMP1 inner mitochondrial membrane peptidase-likeIMP1IMMP1Mitochondrial inner membrane protease subunit 1FLJ25059IMP1-like proteinIMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae)
02

Mechanism of action

Not applicable. There is no known drug mechanism targeting IMMP1L.

03

Biological functions

Processing mitochondrial proteins: Cleavage of mitochondrial targeting presequences from nuclear-encoded proteins imported into the mitochondrial inner membraneProtein maturation in mitochondria: Generation of functional proteins in mitochondrial compartments
04

Disease associations

Ocular developmental disorders (by position): Deletions covering IMMP1L (along with other genes) in 11p13 chromosomal region are associated with developmental ocular diseases including aniridia and ocular coloboma. However, clinical impact appears to relate more to nearby genes such as PAX6 than direct IMMP1L disruptionOther: Some functional studies highlight the location within a broader critical region for neurodevelopment and mitochondrial function, but direct disease links remain unprovenRoles experimentally described for similar enzymes include potential impact on aging and cellular oxidative stress, though for IMMP1L specifically, these are inferred from animal studies and paralogs rather than human clinical data

Beyond the preview

Go deeper on Inner mitochondrial membrane peptidase subunit 1 (IMMP1L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inner mitochondrial membrane peptidase subunit 1 (IMMP1L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call